Tesamorelin — 5 mg & 10 mg
Price range: $ 70.00 through $ 100.00 - or subscribe
Tesamorelin is a 44-amino-acid stabilized analog of growth hormone-releasing hormone (GHRH) that is FDA-approved (as Egrifta) for HIV-associated lipodystrophy and is studied in research for visceral fat metabolism and body composition.
Research-grade specs
- Sequence length: 44 amino acids
- Class: GHRH analog
- Half-life: ~26 minutes
- Pharmaceutical equivalent: Egrifta (FDA-approved 2010)
Studied applications
- Visceral adipose tissue research
- Body-composition and lipid metabolism studies
- Comparative GHRH-analog research (vs Sermorelin, CJC-1295)
- Stack research with Ipamorelin (GHRH + GHRP)
Quality & trust
- ≥99% HPLC purity, third-party tested
- Mass spectrometry identity confirmation
- LAL endotoxin testing on every batch
- Batch-specific Certificate of Analysis included
- USA same-day shipping (orders before 2pm CT M-F)
Related research: Sermorelin · Ipamorelin · Tesamorelin + Ipamorelin blend
Research literature
Tesamorelin has been the subject of 112 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference:
- Chege BM et al. (2026). Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model. Braz J Med Biol Res. PMID: 42018810
- Mendias CL et al. (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID: 41966639
- Uçaktürk E et al. (2026). Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry. J Pharm Biomed Anal. PMID: 41138283
- Arora G et al. (2026). Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss. J Clin Med. PMID: 41598480
- Rahman OF et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200
References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 67.20 | 4% |
| 6-8 | $ 64.40 | 8% |
| 10-15 | $ 62.30 | 11% |
| 16+ | $ 70.00 | $ 0.00 |
Description
Tesamorelin is supplied here as a research-grade GHRH analog in lyophilized peptide vial format, available in 5 mg and 10 mg packs for laboratory studies. Each lot undergoes laboratory testing for purity and identity to support reproducible in-vitro research. This product is intended strictly for laboratory and experimental research purposes; it is not a medicine, dietary supplement, or veterinary product. Any introduction into humans or animals is prohibited by law. Researchers can refer to published literature for background on tesamorelin’s investigational use in controlled studies. Please ensure appropriate institutional approvals and compliance with all local, state, and federal regulations before purchasing or using this material. For more details and supporting references, see the product page.
Reference Link: Click Here
You may also like
5-Amino-1MQ — NNMT Inhibitor | Research Grade
$ 45.99 - or subscribe and save up to 10%
BPC-157 Peptide — Body Protection Compound | Research Grade
$ 85.99 - or subscribe
CJC-1295 ( no DAC) + IPAMORELIN
Price range: $ 85.00 through $ 115.00 - or subscribe
